Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

HHS Directs $100M for Covid-19 Venture Investments

Global Covid-19

The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments

Infographic – Some Good Corporate Venture Fund News

Bar chart: Corporate venture funding by quarter, 2019-2023

Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up. . . . → Read More: Infographic – Some Good Corporate Venture Fund News

Regeneron Acquires Hearing Loss Biotech in $213M Deal

Headphones sound waves graphic

Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders. . . . → Read More: Regeneron Acquires Hearing Loss Biotech in $213M Deal

Long-Acting Drug Start-Up Raises $4M in Seed Funds

Human machine interface

A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds. . . . → Read More: Long-Acting Drug Start-Up Raises $4M in Seed Funds

Digital Chemistry Start-Up Gains $43M in Early Funds

Molecule model in an open hand

A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds

Infographic – Digital Health Venture Funds Remain Stuck

Bar chart: Digital health venture funding worldwide, by quarter

Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years. . . . → Read More: Infographic – Digital Health Venture Funds Remain Stuck

Cancer Immunotherapy Biotech Issues $80M IPO

Wall Street sign

A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO

Infographic – U.S. Life Science Venture Activity Keeps Falling

Bar chart: U.S. life science venture investments by quarter

Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years. . . . → Read More: Infographic – U.S. Life Science Venture Activity Keeps Falling

Venture Fund to Back Life Science A.I. Start-Ups

Synthetic biology

A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups

Infographic – Venture Funds Continue Slide in Q2

Bar chart: Global venture capital investment dollars by quarter to Q2 2023

Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year. . . . → Read More: Infographic – Venture Funds Continue Slide in Q2